
Oral misoprostol is an effective agent to augment labor compared with intravenous oxytocin, according to a study published recently in Obstetrics & Gynecology. India has the largest number of births per year in the world, 27 million, with greater than 60% occurring at home, according to the World Health Organization….
Read more »
Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?
Postpartum Haemorrhage (PPH) is commonly defined as a blood loss of 500 ml or more within 24 hours after birth. PPH is the leading cause of maternal mortality in low and middle-income countries and the primary…
Read more »